Stopangin® (Stopangin)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceHexetidineHexetidine
Similar drugsTo uncover
  • Hexoral®
    aerosol locally 
    Johnson & Johnson, LLC     Russia
  • Hexoral®
    solution locally 
    Johnson & Johnson, LLC     Russia
  • Hexetidine
    spray locally 
    YUZHFARM, LLC     Russia
  • Maxcold® Lor
    spray locally 
    Otisipharm, PAO    
  • Stomatidin®
    solution locally 
    Boznalek, AO     Bosnia and Herzegovina
  • Stopangin®
    spray locally 
    Teva Pharmaceutical Enterprises Co., Ltd.     Israel
  • Stopangin®
    solution locally 
    Teva Pharmaceutical Enterprises Co., Ltd.     Israel
    • Dosage form: & nbsptopical solution
    Composition:Active substance: hexiethidine-0.10000 g
    Excipients:
    Methyl salicylate, essential oil of peppermint, cloves of flowers oil, anise essential oil, eucalyptus essential oil, sassafras essential oil, levomenthol, sodium saccharinate monohydrate, citric monohydrate acid, cinnamon dye [Ponso R], polysorbate 60, ethanol 96%, purified water.
    Description:Transparent light red liquid with a specific odor. An insignificant deposit is possible, which does not affect the quality of the preparation.
    Pharmacotherapeutic group:antiseptic
    ATX: & nbsp

    A.01.A.B.12   Hexetidine

    Pharmacodynamics:Antiseptic for topical use. It also has antifungal activity and analgesic properties when applied to the mucous membrane.Stopangin® has an enveloping effect. The effect lasts 10-12 hours.
    Indications:Infectious and inflammatory diseases of the oral cavity and pharynx (tonsillitis, including Vincent's angina, pharyngitis, stomatitis, aphthous ulcers of the mouth, glossitis, periodontitis, gum bleeding). Fungal diseases (thrush) of the oral cavity and larynx before and after surgery on the oral cavity and larynx. Injuries of the oral cavity and larynx. Prevention of infection of the alveoli after extraction of the tooth.
    Hygiene of the oral cavity to eliminate bad breath from the mouth (deodorant). Prevention of superinfection with collapsing tumors of the oral cavity and larynx.
    Contraindications:The drug should not be used with increased sensitivity to the components of the drug, with atrophic pharyngitis, children under 6 years of age, and during pregnancy (I trimester).
    Dosing and Administration:Locally. If the doctor has not appointed otherwise, it is recommended to rinse the mouth cavity (for at least 30 seconds) with a undiluted solution in a volume of 10-15 ml (1 dessert or a tablespoon) twice a day.
    You can also lubricate the oral mucosa with a cotton swab on a stick.This method of use is suitable for use in children.
    The drug should be used after meals or in between meals for 5-7 days.
    Side effects:There may be a temporary burning sensation of the oral mucosa after using the drug, which spontaneously quickly disappears. In exceptional cases, people with hypersensitivity may experience an allergic reaction. Accidental ingestion of the drug during rinsing can cause self-transmitted nausea. In case of unusual reactions, you should consult with your doctor about the advisability of further use of the drug.
    Overdose:Cases of drug overdose are not known.
    Interaction:Not known.
    Special instructions:The drug can be used by adolescents, as well as pregnant women (II and III trimester) and breastfeeding women.
    Children can use the drug only from the age when there is no danger of uncontrolled ingestion of the drug.
    On the advisability of simultaneous application of Stopangin® with other medicines, consult a doctor.
    When appointing a doctor other medications, tell him about the use of Stopangin®.
    In case of worsening of health, temperature increase, ineffectiveness of medical procedures or unusual reactions, you should consult a doctor.
    In case of overdose or accidental ingestion of the drug inside the child, it is necessary to consult a doctor.
    The preparation contains 4% ethanol.
    Effect on the ability to drive transp. cf. and fur:Attention drivers: the drug should be taken no later than 30 minutes before the start of driving.
    Form release / dosage:Topical solution 0.1%.
    Packaging:To 100 ml in bottles of dark glass with a screwed propylene lid with the control of the first opening and a measuring cap. Each vial with instructions for use is placed in a cardboard box.
    Storage conditions:At a temperature of 10 ° C to 25 ° C, in a place protected from light.
    Do not freeze.
    Shelf life:2 years.
    Do not use after the expiration date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:П N014966 / 01
    Date of registration:27.03.2009
    The owner of the registration certificate:Teva Pharmaceutical Enterprises Co., Ltd.Teva Pharmaceutical Enterprises Co., Ltd. Israel
    Manufacturer: & nbsp
    Representation: & nbspTeva Teva Israel
    Information update date: & nbsp2015-12-08
    Illustrated instructions
      Instructions
      Up